The enteral nutrition market offers several advantages such as better tolerance due to administration directly into the gastrointestinal tract, ability to deliver medications and supplements along with nutrients. Enteral nutrition helps in providing nutrition to patients who are unable to meet their daily nutritional needs through normal diet. The Global Enteral Nutrition Market is estimated to be valued at US$ 3.1 Bn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030.
Enteral nutrition contains balanced proteins, vitamins, fiber, and other essential nutrients which help address malnutrition in chronic illness, cancer, neurological disorders, gastrointestinal diseases and other clinical conditions. It is administered through feeding tubes, which provide targeted delivery of nutrition. Rise in prevalence of chronic diseases worldwide, increasing number of preterm birth rates, surge in number of trauma injuries are fueling the demand for enteral nutrition products in the healthcare sector.
Key Takeaways
Key players operating in the Enteral Nutrition are Abbott, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., Curtis Health Caps SP.
Key opportunities in the market include untapped potential of emerging economies, increasing adoption of enteral feeding in home care settings and rise in demand for disease specific enteral formulas.
Globally there is rising acceptance of enteral nutrition as standard of care for management of malnutrition. Leading players are expanding their geographical presence in emerging regions of Asia Pacific, Latin America, Middle East and Africa through acquisitions and partnerships with local players.
Market Drivers
Rising prevalence of chronic diseases such as cancer, gastrointestinal disorders is a major factor driving the demand for enteral nutrition. According to WHO estimates cancer burden is expected to grow by 73% in next 20 years.
Market Restrains
Complications associated with tube feeding such as infections, tube misplacement can negatively impact the market growth. Additional training required for administering enteral nutrition through feeding tubes and pumps also acts as a restrain. preference for parenteral nutrition in critical care is another challenge for enteral nutrition market.
Segment Analysis
The enteral nutrition market is dominated by the standard formula sub segment due to increasing preference for standard formulas over disease specific formulas. Standard formulas have a high demand owing to their cost-effectiveness and capability to cater to general nutritional requirements. The standard formula sub segment accounts for over 60% market share.
Global Analysis
The North America region dominates the enteral nutrition market. The high affordability and spending on healthcare in countries like the US and Canada are major factors driving the North American market. The region accounts for over 35% of the global market share. Asia Pacific is projected to be the fastest growing market during the forecast period. Factors such as increasing healthcare expenditure, rising awareness about enteral nutrition and a large patient pool make Asia Pacific an attractive market for enteral nutrition product manufacturers.
Comments
0 comment